Product Information

IBUPROFEN 800 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.0507 per EA under NDC 64380080707. Its NADAC has been published 429 times since Sep 5, 2018.

FDA first approved this application on Feb 5, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

IBUPROFEN 800 MG TABLET

Ibuprofen
$0.0507per EA

Strength

800 mg/1

NDC

64380080707

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

IBUPROFEN

Approval Type

Generic (ANDA)

FDA Application

ANDA078329

FDA Approved

2/5/2009

TE Code

AB

On Market Since

8/24/2018

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for IBUPROFEN 800 MG TABLET has been published 429 times since Sep 5, 2018, and over the history we have for it it has declined 17.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0507 per EA
All-time high$0.0933 (Mar 11, 2020)
All-time low$0.0507 (Nov 18, 2026)
52-week high$0.0585
52-week low$0.0507
Median price$0.0680
Average price$0.0695
Largest weekly change-20.3% (Apr 17, 2024)
Weeks tracked429
Tracking sinceSep 5, 2018

Price History

1W

-8.6%

1M

-11.4%

3M

-13.3%

6M

-10.6%

1Y

-11.0%

3Y

-22.1%

5Y

-35.3%

All

-17.9%

Generic Alternatives

The matcher finds 15 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of IBUPROFEN 800 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 800 MG TABLET, manufactured by Strides Pharma Inc., is $0.0507 per EA (NDC 64380080707), effective Nov 18, 2026.

How has the price of IBUPROFEN 800 MG TABLET changed over time?

Over the history we have for it, the NADAC for IBUPROFEN 800 MG TABLET has declined 17.9%. It has been tracked across 429 weekly CMS publications since Sep 5, 2018.

What are the highest and lowest recorded NADAC prices for IBUPROFEN 800 MG TABLET?

Since Sep 5, 2018, the NADAC for IBUPROFEN 800 MG TABLET has ranged from a low of $0.0507 (Nov 18, 2026) to a high of $0.0933 (Mar 11, 2020), with a median of $0.0680 per EA.

Are there cheaper alternatives to IBUPROFEN 800 MG TABLET?

15 manufacturers publish a NADAC-priced product with the same active ingredient and strength as IBUPROFEN 800 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures IBUPROFEN 800 MG TABLET?

IBUPROFEN 800 MG TABLET (NDC 64380080707) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.